Radiation Oncology Journal10.3857/roj.2013.31.3.1112013313111Fluorodeoxyglucose positron-emission tomography ratio in non-small cell lung cancer patients treated with definitive radiotherapyHyun-Cheol Kang, Hong-Gyun Wu, Tosol Yu, Hak Jae Kim, Jin Chul Paeng,,
International Journal of Radiation Oncology*Biology*Physics10.1016/j.ijrobp.2007.08.05220087051397-140218F-Fluorodeoxyglucose Positron Emission Tomography-Based Assessment of Local Failure Patterns in Non–Small-Cell Lung Cancer Treated With Definitive RadiotherapySonal Sura, Carlo Greco, Daphna Gelblum, Ellen D. Yorke, Andrew Jackson, Kenneth E. Rosenzweig,
10.21203/ Emission Tomography/Computed Tomography-Guided Chest Radiotherapy Improves Survival in Patients with Extracranial Oligometastatic Non-small Cell Lung CancerTianlu Wang, Chengsen Liu, Yingqiu Song, Zheng Wang, Lei He, Chenyu Wang, Yu Wu, Ye Wang, Xiaofang Zhang, Guang Li,
Lung Cancer10.1016/s0169-5002(12)70141-1201275S46140 FDG positron emission tomography maximum standardised uptake value (SUVmax) has prognostic value in non-small cell lung cancer treated with radical radiotherapyM. Button, A. Caley, R. Cox, C. White,
Lung Cancer10.1016/s0169-5002(15)50148-7201587S55-S56154: Positron emission tomography derived parameters as predictive factors for doubling time of tumour & survival in non-small cell lung cancer patients treated with radical radiotherapyM.H. Khan, A. Chetiyawardana, R. Amir, V. Harrop, K. Sharma Sharma,
Yearbook of Surgery10.1016/s0090-3671(10)79655-520102010442-444Fluorodeoxyglucose positron emission tomography and tumor marker expression in non–small cell lung cancerD.R. Jones,
Yearbook of Oncology10.1016/s1040-1741(08)70170-220062006241-242[18F]Fluorodeoxyglucose Uptake by Positron Emission Tomography Predicts Outcome of Non-Small-Cell Lung CancerN.H. Hanna,
Yearbook of Medicine10.1016/s0084-3873(08)70399-720062006134-135[18F]Fluorodeoxyglucose Uptake by Positron Emission Tomography Predicts Outcome of Non–Small-Cell Lung CancerN.H. Hanna,
Lung Cancer10.1016/s0169-5002(17)30055-72017103S35: What is the relationship between F-18-fluorodeoxyglucose positron emission tomography (FDG-PET) characteristics and outcomes in continuous hyperfractionated accelerated radiotherapy (CHART) for non-small cell lung cancer (NSCLC)?R. Rulach, R. Fullerton, S. Han, F. Hendry, D. Colville, R. Jones,
Clinical Lung Cancer10.1016/s1525-7304(11)70281-9200344213-216Fluorodeoxyglucose Positron Emission Tomography as a Staging and Prognostic Tool in Non–Small-Cell Lung CancerHeather DeGrendele, Chandra P. Belani, Ralph Naumann, Charles White,